Riskpilot← Back to searchSign inGet full accessPerbio Science Invest AB
ABDissolvedOrg 5565793865Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 19990 employees
Revenue 2020
SEK 0
EBITDA margin
—
-5900% vs 2019
Equity ratio
98.9%
Financial strength
Net profit 2020
SEK -60K
-5900% vs 2019
| Revenue | SEK 0 | — |
| EBITDA | SEK -60K | -5900% |
| Net profit | SEK -60K | -5900% |
| Total assets | SEK 5,1M | -1% |
| Equity | SEK 5M | -1% |
| Employees | 0 | — |
Legal name
Perbio Science Invest AB
Org number
5565793865
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
9 november 1999
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Company purpose
Bolaget skall äga, förvalta och förädla fast och lös egendom, däribland värdepapper, samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −52 | −44 | −60 | −1 | −60 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −52 | −44 | −60 | −1 | −60 |
| Net financials | −1 | — | — | — | — |
| Profit before tax | −53 | −44 | −60 | −1 | −60 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −53 | −44 | −60 | −1 | −60 |
| Item | 2017 | 2018 | 2019 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 5 268 | 5 225 | 5 173 | 5 135 | 5 073 |
| Equity | 5 180 | 5 137 | 5 077 | 5 076 | 5 015 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 87 | 89 | 96 | 59 | 58 |
| Total debt | 87 | 89 | 96 | 59 | 58 |
EBITDA margin
-6000000.0%
This company
15.8%
Market median
-37974784% vs market
20172020
Equity ratio
98.9%
This company
38.2%
Market median
+159% vs market
20172020
Return on equity
-1.2%
This company
18.4%
Market median
-107% vs market
20172020
Net profit margin
-6000000.0%
This company
8.1%
Market median
-74074174% vs market
20172020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172020
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20172020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-12-01 – 2019-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-12-01 – 2019-11-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-11-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
VG Authorized Recipient of Service | Authorized Recipient of Service | 2020 |
AG Chief Auditor | Chief Auditor | 2020 |
| Former (1) | ||
HC Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Perbio Science Invest AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hanna Chainikova | Authorized Recipient of Service | 0 companies |
| Valerio Gaddi | Authorized Recipient of Service | 0 companies |
| Anders Göran Magnussen | Chief Auditor | 0 companies |
| Marcel Jacobus van der Meijden | Board of Directors | 0 companies |
| Anthony Hugh Smith | Board of Directors | 0 companies |
| Petrus Thomas Adrianus van der Zande | Chairman | 0 companies |